Eli Lilly Has a Major Problem With Its Weight Loss Drugs Zepbound and Mounjaro

Eli Lilly, the maker of the popular weight loss drug Zepbound, revealed what Bloomberg called a "shocking first miss" during its most recent quarterly sales. ... Read more

Bron:

Futurism

Tags: Eli Lilly

Geplaatst: 02 Nov 2024 - 15:30

Related articles:

Eli Lilly Posts a Huge Earnings Miss. Should Investors Be Worried? (Fool.com: The Motley Fool)
Americans seeking Eli Lilly and Novo Nordisk's weight-loss drugs turn to compounded market (Fast Company)
Prescriptions for weight loss drugs rise 40% in the Netherlands (DutchNews.nl)
Smoothie King launches special menu for Ozempic users: 'Thoughtful balance' (NY Post: National News)